These CD19hi/FSChi B cells expressed activation and memory markers and higher IgG and IgM production, and are thought to represent the activated pathological CD19hi B cells subset found in the periphery of SLE patients (Liu et al, 2017b). The gene discussed is CD40LG; the disease is systemic lupus erythematosus.